Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07683117 · ClinicalTrials.gov registry record · NA
PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
A NA study, sponsored by EMPOWERX.
- Recruiting
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT07683117 is a NA study that is actively recruiting participants, run by EMPOWERX. The registered enrollment target is 195 participants.
The verdict
NCT07683117, a NA study, is actively recruiting participants, sponsored by EMPOWERX.
- RECRUITING
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does the PEPPI software make it easier for patients to access PEP/PrEP? Researchers will compare pharmacists' implementation and patients' access when using the PEPPI software and when not using the PEPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide PEP/PrEP services as normal while using the PEPPI software. Patients will be asked to receive PEP/PrEP services from a pharmacist as normal, while using the PEPPI software.
Interventions
- OTHER PEPPI Pharmacies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2026-08 |
| Est. Completion | 2028-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07683117
The ClinicalTrials.gov registry entry for NCT07683117 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMPOWERX, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEPPI Pharmacies is the first listed.
NCT07683117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07683117 about?
NCT07683117 is a clinical study titled "PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)". The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does th...
What is the current status of trial NCT07683117?
This trial is currently recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2026-08. Estimated completion is 2028-09.
What interventions are being tested in trial NCT07683117?
The interventions under investigation include: PEPPI Pharmacies (OTHER).
Who is sponsoring clinical trial NCT07683117?
This trial is sponsored by EMPOWERX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.